Login

Consolidated Balance Sheets

In USD, except per-share amounts
Q1 FY2027
As of Jul 31, 2026
Q4 FY2026
As of Apr 30, 2026
Q3 FY2026
As of Jan 31, 2026
Q2 FY2026
As of Oct 31, 2025
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Account receivables
Deposit & prepayment
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS
Equipment & furniture, net
Right of use assets, net
Software, net
Furniture, net
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accrued expenses and other payables
Income tax payable
Lease liability
Amount due to a director
TOTAL CURRENT LIABILITIES
NON-CURRENT LIABILITIES
Lease liability
TOTAL LIABILITIES
STOCKHOLDERS’ EQUITY
Common stock – Par value $0.0001; Authorized: 50,000,000 Issued and outstanding: 25,912,500 shares as of July 31, 2026 and April 30, 2026
Additional paid-in capital
Accumulated other comprehensive loss
Retained profit / (Accumulated deficit)
TOTAL STOCKHOLDERS’ FUND
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support